Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.4103/ijmr.IJMR_3092_20

http://scihub22266oqcxt.onion/10.4103/ijmr.IJMR_3092_20
suck pdf from google scholar
33818467!8184072!33818467
unlimited free pdf from europmc33818467    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33818467      Indian+J+Med+Res 2021 ; 153 (1 & 2): 64-85
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Use of convalescent plasma for COVID-19 in India: A review & practical guidelines #MMPMID33818467
  • Khaire NS; Jindal N; Yaddanapudi LN; Sachdev S; Hans R; Sachdeva N; Singh MP; Agarwal A; Mukherjee A; Kumar G; Sharma RR; Suri V; Puri GD; Malhotra P
  • Indian J Med Res 2021[Jan]; 153 (1 & 2): 64-85 PMID33818467show ga
  • Convalescent plasma (CP) therapy is one of the promising therapies being tried for COVID-19 patients. This passive immunity mode involves separating preformed antibodies against SARS-CoV-2 from a recently recovered COVID-19 patient and infusing it into a patient with active disease or an exposed individual for prophylaxis. Its advantages include ease of production, rapid deployment, specificity against the target infectious agent, and scalability. In the current pandemic, it has been used on a large scale across the globe and also in India. However, unequivocal proof of efficacy and effectiveness in COVID-19 is still not available. Various CP therapy parameters such as donor selection, antibody quantification, timing of use, and dosing need to be considered before its use. The current review attempts to summarize the available evidence and provide recommendations for setting up CP protocols in clinical and research settings.
  • |Antibodies, Neutralizing[MESH]
  • |Antibodies, Viral[MESH]
  • |COVID-19 Serotherapy[MESH]
  • |COVID-19/*therapy[MESH]
  • |Humans[MESH]
  • |Immunization, Passive[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box